Ekso is one of the most-researched exoskeletons in the world.

EKSOHEALTH RESEARCH

World-renowned institutions are leading the charge in exoskeleton research on acquired brain injury, stroke, spinal cord injury, multiple sclerosis, and more with Ekso.

With countless partners like Johns Hopkins, Shirley Ryan AbilityLab, Kessler Institute, the Department for Veteran’s Affairs, UCLA, and more, Ekso’s technology is based on clinical expertise and feedback from industry leaders. We are excited to offer innovative rehabilitative exoskeletons like Ekso for upper-extremities and EksoNR, the world’s only FDA-approved exoskeleton for the treatment of ABI.

EKSOHEALTH STUDIES

Continuing to Drive Research.

Since 2012, we have sponsored or supported mostly investigator-initiated clinical research utilizing our medical devices. As of July 2020, there were 74 completed and 36 ongoing studies. These 110 studies have involved more than 1,800 participants in the US and abroad. Many of the feasibility studies have led to larger studies (single-arm or comparative), where the investment of time and resources is considerable. We remain committed to demonstrating clinical benefit through research.

EKSOHEALTH CLINICAL PUBLICATIONS

Publications & Presentations

Past research activity using Ekso devices has culminated in more than 110 conference presentations, chapters, and published articles, including 18 review articles. Of these published articles, the studies examine patients of spinal cord injury (55), stroke (13), traumatic or acquired brain injury excluding stroke (two), generalized weakness/ paralysis/ gait disorders (three), and multiple sclerosis (three). In addition to gait function, 2020 publications have focused on utilization in inpatient rehabilitation, patient perspectives, muscle synergies and activation, and energy expenditure.

Download Our Latest Research

Ekso Clinical Research Summary

Proven success with EksoWorks.

Customers and institutions alike have studied the efficacy and usability of Ekso in the industrial sector. Studies have shown that Ekso, engineered with optimized load paths, can reduce spinal stress, shoulder strain, and task completion time.

According to Virginia Tech, trunk extension and spinal twisting under load, both infamous for causing back injury, are reduced by EksoVest (the first evolution of EVO). 

Virginia Tech also found a reduction in shoulder muscle activity levels during shoulder flexion and abduction with EksoVest, suggesting it supports and unloads the shoulder complex during activities that are typically shoulder-straining. Additionally, if one has an imbalance in arm strength, Ekso can help the ‘weaker’ arm contribute more during bi-manul lifting, reducing spinal stress.